CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer (Q41751613)

8 October 2017

title

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer (English)

1 reference

8 October 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Francesco Petrella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Sara Raimondi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Lorenzo Spaggiari

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

6

Massimo Barberis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

12

Massimo Bellomi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

10

Filippo De Marinis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

9

Cristiano Rampinelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Valentina Buscarino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Federica De Maria

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Caterina Fumagalli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Gianluca Spitaleri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

9 May 2015

1 reference

8 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

32-42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25956936%20AND%20SRC:MED&resulttype=core&format=json

Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Ceritinib in ALK-rearranged non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Management and future directions in non-small cell lung cancer with known activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Measurement of observer agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Molecular genetic testing for lung adenocarcinomas: a practical approach to clinically relevant mutations and translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

KRAS mutations as prognostic and predictive markers in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Coexisting pulmonary nodules in operable lung cancer: prevalence and probability of malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-015-3814-0

Pleural retraction and intra-tumoral air-bronchogram as prognostic factors for stage I pulmonary adenocarcinoma following complete resection

21 January 2018

1 reference

12 December 2020

Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT.

1 reference

12 December 2020

Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity

1 reference

12 December 2020

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

1 reference

12 December 2020

Clinical significance of ras oncogene activation in human lung cancer

1 reference

12 December 2020